John Hernandez's most recent trade in Resmed Inc. was a trade of 2,575 ResMed Common Stock done at an average price of $287.1 . Disclosure was reported to the exchange on Aug. 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ResMed | John Hernandez | Director | Sale of securities on an exchange or to another person at price $ 287.10 per share. | 18 Aug 2025 | 2,575 | 4,045 (0%) | 0% | 287.1 | 739,289 | ResMed Common Stock |
| ResMed | John Hernandez | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2025 | 2,575 | 0 | - | - | ResMed Common Stock Options | |
| ResMed | John Hernandez | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 148.90 per share. | 18 Aug 2025 | 2,575 | 6,620 (0%) | 0% | 148.9 | 383,418 | ResMed Common Stock |
| ResMed | John Hernandez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2024 | 1,083 | 4,045 (0%) | 0% | 0 | ResMed Common Stock | |
| ResMed | John Hernandez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Nov 2023 | 2,575 | 2,575 | - | - | ResMed Common Stock Options | |
| ResMed | John Hernandez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Nov 2023 | 884 | 2,962 (0%) | 0% | 0 | ResMed Common Stock | |
| ResMed | John Hernandez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Nov 2022 | 1,122 | 2,078 (0%) | 0% | 0 | ResMed Common Stock |